Roberto Andini

2.7k total citations
31 papers, 850 citations indexed

About

Roberto Andini is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Roberto Andini has authored 31 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 13 papers in Infectious Diseases and 10 papers in Molecular Medicine. Recurrent topics in Roberto Andini's work include Antibiotic Resistance in Bacteria (10 papers), Infective Endocarditis Diagnosis and Management (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Roberto Andini is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Infective Endocarditis Diagnosis and Management (9 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Roberto Andini collaborates with scholars based in Italy, United Kingdom and United States. Roberto Andini's co-authors include Emanuele Durante‐Mangoni, Antonio Corcione, Rosa Zampino, Raffaele Zarrilli, Patrizia Murino, Riccardo Utili, Nicola Galdieri, Lorenzo Bertolino, Nicola Petrosillo and Claudio Viscoli and has published in prestigious journals such as Clinical Infectious Diseases, Medicine and Clinical Microbiology and Infection.

In The Last Decade

Roberto Andini

27 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Andini Italy 14 423 300 289 281 160 31 850
Renato Pascale Italy 17 334 0.8× 286 1.0× 240 0.8× 203 0.7× 229 1.4× 60 849
Yanina Dubrovskaya United States 18 294 0.7× 368 1.2× 347 1.2× 248 0.9× 121 0.8× 52 879
Maristela Pinheiro Freire Brazil 23 545 1.3× 511 1.7× 263 0.9× 189 0.7× 168 1.1× 71 1.3k
Matthaios Papadimitriou‐Olivgeris Switzerland 19 530 1.3× 490 1.6× 205 0.7× 552 2.0× 299 1.9× 98 1.3k
Linda Bussini Italy 14 251 0.6× 221 0.7× 153 0.5× 274 1.0× 188 1.2× 34 682
Amanda Paschke United States 14 657 1.6× 478 1.6× 539 1.9× 318 1.1× 343 2.1× 32 1.2k
Brian Nelson United States 11 396 0.9× 223 0.7× 266 0.9× 156 0.6× 226 1.4× 16 668
Giusy Tiseo Italy 22 890 2.1× 533 1.8× 539 1.9× 382 1.4× 483 3.0× 62 1.6k
Matteo Rinaldi Italy 15 251 0.6× 319 1.1× 308 1.1× 217 0.8× 122 0.8× 78 900
Rujipas Sirijatuphat Thailand 10 266 0.6× 187 0.6× 177 0.6× 260 0.9× 118 0.7× 34 651

Countries citing papers authored by Roberto Andini

Since Specialization
Citations

This map shows the geographic impact of Roberto Andini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Andini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Andini more than expected).

Fields of papers citing papers by Roberto Andini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Andini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Andini. The network helps show where Roberto Andini may publish in the future.

Co-authorship network of co-authors of Roberto Andini

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Andini. A scholar is included among the top collaborators of Roberto Andini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Andini. Roberto Andini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertolino, Lorenzo, Ahsanullah Unar, Fabian Patauner, et al.. (2024). Embolic complications in a large contemporary cohort of infective endocarditis: do we need score model?. Infection. 53(3). 1101–1113.
2.
Zampino, Rosa, Domenico Iossa, Arta Karruli, et al.. (2023). Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital. International Journal of Antimicrobial Agents. 62(2). 106883–106883. 8 indexed citations
3.
Karruli, Arta, et al.. (2023). Clinical efficacy and safety of cefiderocol for resistant Gram-negative infections: a real-life, single-centre experience. International Journal of Antimicrobial Agents. 61(2). 106723–106723. 15 indexed citations
4.
Durante‐Mangoni, Emanuele, Maria Paola Ursi, Roberto Andini, et al.. (2022). Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction. Journal of Clinical Medicine. 11(24). 7357–7357. 4 indexed citations
5.
Karruli, Arta, Roberto Andini, Domenico Iossa, et al.. (2021). Risk Factors and Outcome of Multidrug-Resistant Infections after Heart Transplant: A Contemporary Single Center Experience. Microorganisms. 9(6). 1210–1210. 7 indexed citations
6.
Ramadan, Mohammad, Marina Lugarà, Michele Gambardella, et al.. (2021). Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review. Journal of Chemotherapy. 34(6). 360–366. 6 indexed citations
7.
Ramadan, Mohammad, Lorenzo Bertolino, Rosa Zampino, et al.. (2021). Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review. Clinical Microbiology and Infection. 27(9). 1250–1261. 73 indexed citations
8.
Zampino, Rosa, Domenico Iossa, Maria Paola Ursi, et al.. (2021). Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis. BMC Infectious Diseases. 21(1). 23–23. 8 indexed citations
9.
Karruli, Arta, Filomena Boccia, Massimo Gagliardi, et al.. (2021). Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience. Microbial Drug Resistance. 27(9). 1167–1175. 47 indexed citations
10.
Durante‐Mangoni, Emanuele, Roberto Andini, Lorenzo Bertolino, et al.. (2020). Early experience with remdesivir in SARS-CoV-2 pneumonia. Infection. 48(5). 779–782. 26 indexed citations
11.
Durante‐Mangoni, Emanuele, Roberto Andini, Lorenzo Bertolino, et al.. (2020). Real-life experience with ceftobiprole in a tertiary-care hospital. Journal of Global Antimicrobial Resistance. 22. 386–390. 19 indexed citations
12.
Zampino, Rosa, Ferruccio Mele, Lorenzo Bertolino, et al.. (2020). Liver injury in remdesivir-treated COVID-19 patients. Hepatology International. 14(5). 881–883. 109 indexed citations
13.
Durante‐Mangoni, Emanuele, Filomena Boccia, Maria Paola Ursi, et al.. (2020). Dalbavancin for infective endocarditis: a single centre experience. Journal of Chemotherapy. 33(4). 256–262. 13 indexed citations
14.
Andini, Roberto, et al.. (2017). Direct antiviral treatment of chronic hepatitis C in heart transplant recipients. Transplant Infectious Disease. 20(1). 5 indexed citations
15.
Iossa, Domenico, Luca Rinaldi, Pia Clara Pafundi, et al.. (2017). Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact. Journal of Clinical Virology. 96. 54–59. 4 indexed citations
16.
Durante‐Mangoni, Emanuele, et al.. (2016). Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis. International Journal of Antimicrobial Agents. 48(1). 61–68. 23 indexed citations
17.
Durante‐Mangoni, Emanuele, Mariateresa Del Franco, Roberto Andini, et al.. (2015). Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii. Diagnostic Microbiology and Infectious Disease. 82(3). 222–226. 49 indexed citations
18.
Durante‐Mangoni, Emanuele, Roberto Andini, Federica Agrusta, et al.. (2014). Infective endocarditis due to multidrug resistant gram-negative bacilli: Single centre experience over 5years. European Journal of Internal Medicine. 25(7). 657–661. 13 indexed citations
19.
Durante‐Mangoni, Emanuele, et al.. (2014). Differential Antiviral Effects of Pegylated Interferon-α2a and Pegylated Interferon-α2b in Chronic Hepatitis C. Clinical Drug Investigation. 34(12). 871–878.
20.
Durante‐Mangoni, Emanuele, Giuseppe Signoriello, Roberto Andini, et al.. (2013). Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial. Clinical Infectious Diseases. 57(3). 349–358. 311 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renato Pascale Breakdown of academic impact, for papers by Yanina Dubrovskaya Breakdown of academic impact, for papers by Maristela Pinheiro Freire Breakdown of academic impact, for papers by Matthaios Papadimitriou‐Olivgeris Breakdown of academic impact, for papers by Linda Bussini Breakdown of academic impact, for papers by Amanda Paschke Breakdown of academic impact, for papers by Brian Nelson Breakdown of academic impact, for papers by Giusy Tiseo Breakdown of academic impact, for papers by Matteo Rinaldi Breakdown of academic impact, for papers by Rujipas Sirijatuphat
Rankless by CCL
2026